Sunday, August 23, 2026
23.6 C
Bengaluru

Sachhin Misshra has been elevated to the role of President at Akumentis Healthcare.

Sachhin Misshra has been elevated to the role of President at Akumentis Healthcare.

With over nine years at the organization and more than 25 years of experience in the pharmaceutical industry, he brings deep insight into how innovation and focused sales and marketing strategies can drive meaningful improvements in patient outcomes.

In his new role, he will lead the company’s core “One Gynaec” mission. By aligning its specialized divisions, Akumentis Healthcare aims to build a unified, high-impact ecosystem dedicated to gynaecology and infertility. He will be steering the organization toward scaling new milestones, introducing transformative products, and strengthening its position within the Indian pharmaceutical landscape.

He also expressed his gratitude to Executive Director Mr. Kanishk Jain, CEO Mr. Ajay Dhiman, along with mentors, colleagues, and the broader healthcare community for their continued trust and support.

Hot this week

Will Mounjaro Disrupt Existing Therapy Areas Like Cardiology?

Something remarkable has happened in the Indian pharmaceutical market....

Can India Pivot From Low-Cost Medical Tourism to Trusted Medical Value Travel?

C-Suite Executive Summary India stands at a pivotal juncture in...

Rajesh Bhogavalli has been appointed as Chief Commercial Officer of ACG Group.

With over 25 years of leadership experience across commercial...

Will President Trump’s Diktat Improve Drug Quality For Indian Patients?

Executive Summary The geopolitical landscape of pharmaceutical manufacturing is shifting...

Mounjaro is the Exceptional Growth Story: Ranks #1

The July Brand Monitor by Pharmarack shows a healthy...

Topics

Will Mounjaro Disrupt Existing Therapy Areas Like Cardiology?

Something remarkable has happened in the Indian pharmaceutical market....

Can India Pivot From Low-Cost Medical Tourism to Trusted Medical Value Travel?

C-Suite Executive Summary India stands at a pivotal juncture in...

Will President Trump’s Diktat Improve Drug Quality For Indian Patients?

Executive Summary The geopolitical landscape of pharmaceutical manufacturing is shifting...

Mounjaro is the Exceptional Growth Story: Ranks #1

The July Brand Monitor by Pharmarack shows a healthy...

Sun Pharma: In the Eye of the Storm of Ophthalmologists

The Two-Tier Reality of Indian Pharma: Patient Safety, Pharmacovigilance,...

Does India Need to Reinvent the Wheel on Junk Foods?

In a written reply in the Lok Sabha in...
spot_img

Related Articles

spot_imgspot_img